Matthew E. Falagas
Impact in
- Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria
- Applied Microbiology and Biotechnology top 0.01%
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Use and Resistance 68
-
- Antibiotic Resistance in Bacteria 162
- Co-authors
- Konstantinos Z. VardakasDrosos E. KarageorgopoulosPetros I. RafailidisΓεώργιος ΠαππάςArgyris MichalopoulosEleni PitsouniGeorge MalietzisIoannis A. Bliziotis
- Journals
- International Journal of Antimicrobial Agents (50 papers)European Journal of Clinical Microbiology & Infectious Diseases (33 papers)Expert Review of Anti-infective Therapy (21 papers)PLoS ONE (20 papers)Journal of Antimicrobial Chemotherapy (19 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Matthew E. Falagas
585 papers receiving 46.9k citations
Hit Papers
Peers
Comparison fields: 5 of 231
- Molecular Medicine 17.2k
- Applied Microbiology and Biotechnology 5.3k
- Endocrinology 5.0k
- Critical Care and Intensive Care Medicine 3.2k
- Clinical Biochemistry 3.9k
Countries citing papers authored by Matthew E. Falagas
This map shows the geographic impact of Matthew E. Falagas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Falagas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Falagas more than expected).
Fields of papers citing papers by Matthew E. Falagas
This network shows the impact of papers produced by Matthew E. Falagas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Falagas. The network helps show where Matthew E. Falagas may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Falagas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2019 | 2 | |
| 3 | Fosfomycin Hit paper breakdown → | 2016 | 443 |
| 4 | 2013 | 68 | |
| 5 | 2012 | 4 | |
| 6 | 2012 | 12 | |
| 7 | 2011 | 1 | |
| 8 | Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Hit paper breakdown → | 2011 | 10072 |
| 9 | 2010 | 53 | |
| 10 | 2008 | 113 | |
| 11 | 2008 | 55 | |
| 12 | Cytomegalovirus meningitis in an immunocompetent patient. | 2007 | 9 |
| 13 | 2007 | 10 | |
| 14 | 2007 | 157 | |
| 15 | A prospective study of services utilization of a hospital-based employee health clinic. | 2006 | 2 |
| 16 | 2006 | 70 | |
| 17 | A healthy woman with right upper quadrant discomfort on deep palpation. | 2005 | 1 |
| 18 | 2005 | 143 | |
| 19 | Effectiveness and Safety of Colistin Treatment in Patients with ICU-Acquired Infections due to Multiresistant Gram-Negative Bacteria: the Renaissance of an Old Antibiotic | 2004 | 1 |
| 20 | Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group. | 1997 | 68 |
About Matthew E. Falagas
Matthew E. Falagas is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Critical Care and Intensive Care Medicine, Epidemiology and Pharmacology, having authored 593 papers that have together received 48.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (162 papers), Antibiotics Pharmacokinetics and Efficacy (117 papers), Pneumonia and Respiratory Infections (103 papers), Antibiotic Use and Resistance (68 papers), Nosocomial Infections in ICU (54 papers), Urinary Tract Infections Management (50 papers), Antimicrobial Resistance in Staphylococcus (49 papers) and Bacterial Identification and Susceptibility Testing (44 papers). The work is most often cited by research in Molecular Medicine (17.2k citations), Applied Microbiology and Biotechnology (5.3k citations), Endocrinology (5.0k citations), Critical Care and Intensive Care Medicine (3.2k citations) and Clinical Biochemistry (3.9k citations). Matthew E. Falagas has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Konstantinos Z. Vardakas, Drosos E. Karageorgopoulos, Petros I. Rafailidis, Γεώργιος Παππάς, Argyris Michalopoulos, Eleni Pitsouni, George Malietzis, Ioannis A. Bliziotis, George Samonis and Alkiviadis Vatopoulos. Their work appears in journals such as International Journal of Antimicrobial Agents, European Journal of Clinical Microbiology & Infectious Diseases, Expert Review of Anti-infective Therapy, PLoS ONE and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.